# Antimicrobial Susceptibility and Genetic Epidemiology of Extended-Spectrum β-Lactamase-Positive Enterobacterales Clinical Isolates in Central Poland

**Authors:** Małgorzata Brauncajs, Filip Bielec, Anna Macieja, Piotr Machnicki, Dorota Pastuszak-Lewandoska

PMC · DOI: 10.3390/ijms25158371 · International Journal of Molecular Sciences · 2024-07-31

## TL;DR

This study examines antibiotic resistance and genetic patterns in bacteria from central Poland, highlighting the spread of resistance genes.

## Contribution

The study provides new insights into the genetic epidemiology and drug resistance profiles of ESβL-producing bacteria in central Poland.

## Key findings

- Over 50% of isolates were resistant to gentamicin, cefepime, ceftazidime, and ciprofloxacin.
- The blaCTX-M gene was the most commonly detected ESβL gene among the isolates.
- Most isolates had multiple resistance genes, raising concerns about the spread of multidrug resistance.

## Abstract

The extended-spectrum β-lactamases (ESβLs) are bacterial enzymes capable of hydrolyzing penicillins, cephalosporins, and aztreonam. The prevalence of ESβL is increasing among clinically significant microorganisms worldwide, drastically reducing the therapeutic management of infectious diseases. The study aimed to determine the drug susceptibility of ESβL-positive clinical isolates acquired from patients hospitalized in Lodz, central Poland, and analyze the prevalence of specific genes, determining acquired resistance in these bacteria. The samples of ESβL-positive clinical isolates were gathered in 2022 from medical microbiological laboratories in the city of Lodz, central Poland. The strains were subjected to biochemical identification and antimicrobial susceptibility testing following EUCAST guidelines. The presence of studied genes (blaCTX-M, blaSHV, blaTEM, blaPER, blaVEB) was confirmed by PCR. Over 50% of studied isolates were resistant to gentamicin, cefepime, ceftazidime and ciprofloxacin. The most common ESβL gene was blaCTX-M. In most isolates, the resistance genes occurred simultaneously. The blaPER was not detected in any of the tested strains. ESβL-producing strains are largely susceptible to the currently available antibiotics. The observation of the coexistence of different genes in most clinical isolates is alarming.

## Linked entities

- **Genes:** blaCTX-M (CTX-M family extended-spectrum class A beta-lactamase) [NCBI Gene 85161177], bla SHV (class A extended-spectrum beta-lactamase SHV-2) [NCBI Gene 40101717]
- **Chemicals:** penicillins (PubChem CID 2349), cephalosporins (PubChem CID 25058126), aztreonam (PubChem CID 5742832), gentamicin (PubChem CID 3467), cefepime (PubChem CID 5479537), ceftazidime (PubChem CID 5481173), ciprofloxacin (PubChem CID 2764)

## Full-text entities

- **Diseases:** infectious diseases (MESH:D003141)
- **Species:** Homo sapiens (human, species) [taxon 9606], Enterobacterales (order) [taxon 91347]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11312491/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11312491/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC11312491/full.md

---
Source: https://tomesphere.com/paper/PMC11312491